Display options
Cite
Zhang ZS, Wang J, Shen YB, et al. Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy. Oncol Lett. 2015;10(1):379-383doi: 10.3892/ol.2015.3183.
Zhang, Z. S., Wang, J., Shen, Y. B., Guo, C. C., Sai, K. E., Chen, F. R., Mei, X., Han, F. U., & Chen, Z. P. (2015). Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy. Oncology letters, 10(1), 379-383. https://doi.org/10.3892/ol.2015.3183
Zhang, Ze-Shun, et al. "Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy." Oncology letters vol. 10,1 (2015): 379-383. doi: https://doi.org/10.3892/ol.2015.3183
Zhang ZS, Wang J, Shen YB, Guo CC, Sai KE, Chen FR, Mei X, Han FU, Chen ZP. Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy. Oncol Lett. 2015 Jul;10(1):379-383. doi: 10.3892/ol.2015.3183. Epub 2015 May 06. PMID: 26171034; PMCID: PMC4487108.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2015 Jul;10(1):379-383. doi: 10.3892/ol.2015.3183. Epub 2015 May 06.

Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy.

Oncology letters

Ze-Shun Zhang, Jing Wang, You-Bi Shen, Cheng-Cheng Guo, K E Sai, Fu-Rong Chen, Xin Mei, F U Han, Zhong-Ping Chen

Affiliations

  1. Department of Neurosurgery, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong 510120, P.R. China.
  2. Department of Neurosurgery/Neuro-Oncology, Sun Yat-Sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong 510060, P.R. China.

PMID: 26171034 PMCID: PMC4487108 DOI: 10.3892/ol.2015.3183

Abstract

Artemisinin, a powerful antimalarial medicine, is extracted from the Chinese herb,

Keywords: autophagy; dihydroartemisinin; glioma; temozolomide

References

  1. Lancet Oncol. 2009 May;10 (5):459-66 - PubMed
  2. Mol Pharmacol. 2003 Aug;64(2):382-94 - PubMed
  3. Science. 1985 May 31;228(4703):1049-55 - PubMed
  4. Trans R Soc Trop Med Hyg. 1984;78(2):265-70 - PubMed
  5. J Natl Cancer Inst. 1993 May 5;85(9):704-10 - PubMed
  6. N Engl J Med. 2001 Jan 11;344(2):114-23 - PubMed
  7. Cell Death Differ. 2004 Apr;11(4):448-57 - PubMed
  8. Cancer Res. 1986 Aug;46(8):4109-15 - PubMed
  9. Neuro Oncol. 2013 Oct;15(10):1353-65 - PubMed
  10. Neurotox Res. 2000;2(1):37-49 - PubMed
  11. Int J Cancer. 2009 Sep 15;125(6):1266-75 - PubMed
  12. Cancer Lett. 2002 May 28;179(2):151-6 - PubMed
  13. Malar J. 2009 May 26;8:112 - PubMed
  14. Neuro Oncol. 2012 Aug;14(8):1062-9 - PubMed
  15. FEBS Open Bio. 2012 May 23;2:103-12 - PubMed
  16. Front Oncol. 2014 May 19;4:116 - PubMed
  17. No Shinkei Geka. 2008 Jun;36(6):473-91 - PubMed
  18. Curr Med Chem. 2003 Nov;10(21):2197-230 - PubMed
  19. Am J Chin Med. 2014;42(2):485-503 - PubMed
  20. Eur J Pharmacol. 2008 Jun 10;587(1-3):65-72 - PubMed
  21. J Cancer Res Clin Oncol. 2006 Feb;132(2):129-35 - PubMed
  22. Int J Cancer. 2010 Sep 1;127(6):1475-85 - PubMed
  23. Semin Oncol. 2003 Dec;30(6 Suppl 19):10-4 - PubMed
  24. Springerplus. 2013 Jul 24;2:340 - PubMed
  25. BMC Cancer. 2014 Aug 25;14 :611 - PubMed
  26. Trends Cell Biol. 2007 Sep;17(9):422-7 - PubMed
  27. Cancer. 1999 Jan 15;85(2):485-91 - PubMed
  28. J Clin Oncol. 2003 Apr 15;21(8):1624-36 - PubMed
  29. Pharmacology. 2008;82(1):1-9 - PubMed
  30. Int J Oncol. 2003 Oct;23(4):1231-5 - PubMed
  31. Anticancer Res. 2014 Jun;34(6):2807-10 - PubMed
  32. N Engl J Med. 2005 Mar 10;352(10 ):987-96 - PubMed
  33. Cell Physiol Biochem. 2014;33(5):1527-36 - PubMed

Publication Types